TY - JOUR AU - Chinese, X. D. R. C. W. G. AU - Guan, X. AU - He, L. AU - Hu, B. AU - Hu, J. AU - Huang, X. AU - Lai, G. AU - Li, Y. AU - Liu, Y. AU - Ni, Y. PY - 2016 DA - 2016// TI - Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant gram-negative bacilli: a Chinese consensus statement JO - Clin Microbiol Infect VL - 22 ID - Chinese2016 ER - TY - JOUR AU - Hu, F. AU - Zhu, D. AU - Wang, F. AU - Wang, M. PY - 2018 DA - 2018// TI - Current status and trends of antibacterial resistance in China JO - Clin Infect Dis VL - 67 UR - https://doi.org/10.1093/cid/ciy657 DO - 10.1093/cid/ciy657 ID - Hu2018 ER - TY - JOUR AU - Grundmann, H. AU - Glasner, C. AU - Albiger, B. AU - Aanensen, D. M. AU - Tomlinson, C. T. AU - Andrasević, A. T. AU - Cantón, R. AU - Carmeli, Y. AU - Friedrich, A. W. AU - Giske, C. G. PY - 2017 DA - 2017// TI - Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study JO - Lancet Infect Dis VL - 17 UR - https://doi.org/10.1016/S1473-3099(16)30257-2 DO - 10.1016/S1473-3099(16)30257-2 ID - Grundmann2017 ER - TY - JOUR AU - Pogue, J. M. AU - Bonomo, R. A. AU - Kaye, K. S. PY - 2019 DA - 2019// TI - Ceftazidime/Avibactam, Meropenem/Vaborbactam, or both? Clinical and formulary considerations JO - Clin Infect Dis VL - 68 UR - https://doi.org/10.1093/cid/ciy576 DO - 10.1093/cid/ciy576 ID - Pogue2019 ER - TY - JOUR AU - Shirley, M. PY - 2018 DA - 2018// TI - Ceftazidime-avibactam: a review in the treatment of serious gram-negative bacterial infections JO - Drugs VL - 78 UR - https://doi.org/10.1007/s40265-018-0902-x DO - 10.1007/s40265-018-0902-x ID - Shirley2018 ER - TY - STD TI - Karlowsky JA, Kazmierczak KM, Bouchillon SK, de Jonge BLM, Stone GG, Sahm DF. In Vitro Activity of Ceftazidime-Avibactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa collected in Latin American countries: results from the INFORM Global Surveillance Program, 2012-2015. Antimicrob Agents Chemother:2019. ID - ref6 ER - TY - JOUR AU - Giddins, M. J. AU - Macesic, N. AU - Annavajhala, M. K. AU - Stump, S. AU - Khan, S. AU - McConville, T. H. AU - Mehta, M. AU - Gomez-Simmonds, A. AU - Uhlemann, A. C. PY - 2018 DA - 2018// TI - Successive emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in blaKPC-2-harboring Klebsiella pneumoniae sequence type 307 isolates JO - Antimicrob Agents Chemother VL - 62 ID - Giddins2018 ER - TY - JOUR AU - Gaibani, P. AU - Campoli, C. AU - Lewis, R. E. AU - Volpe, S. L. AU - Scaltriti, E. AU - Giannella, M. AU - Pongolini, S. AU - Berlingeri, A. AU - Cristini, F. AU - Bartoletti, M. PY - 2018 DA - 2018// TI - In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment JO - J Antimicrob Chemother VL - 73 UR - https://doi.org/10.1093/jac/dky082 DO - 10.1093/jac/dky082 ID - Gaibani2018 ER - TY - JOUR AU - Tzouvelekis, L. S. AU - Markogiannakis, A. AU - Psichogiou, M. AU - Tassios, P. T. AU - Daikos, G. L. PY - 2012 DA - 2012// TI - Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions JO - Clin Microbiol Rev VL - 25 UR - https://doi.org/10.1128/CMR.05035-11 DO - 10.1128/CMR.05035-11 ID - Tzouvelekis2012 ER - TY - JOUR AU - Gutiérrez-Gutiérrez, B. AU - Salamanca, E. AU - Cueto, M. AU - Hsueh, P. -. R. AU - Viale, P. AU - Paño-Pardo, J. R. AU - Venditti, M. AU - Tumbarello, M. AU - Daikos, G. AU - Cantón, R. PY - 2017 DA - 2017// TI - Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study JO - Lancet Infect Dis VL - 17 UR - https://doi.org/10.1016/S1473-3099(17)30228-1 DO - 10.1016/S1473-3099(17)30228-1 ID - Gutiérrez-Gutiérrez2017 ER - TY - JOUR AU - Wang, Q. AU - Wang, X. AU - Wang, J. AU - Ouyang, P. AU - Jin, C. AU - Wang, R. AU - Zhang, Y. AU - Jin, L. AU - Chen, H. AU - Wang, Z. PY - 2018 DA - 2018// TI - Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012-2016) JO - Clin Infect Dis VL - 67 UR - https://doi.org/10.1093/cid/ciy660 DO - 10.1093/cid/ciy660 ID - Wang2018 ER - TY - JOUR AU - Chen, W. AU - Sun, L. AU - Guo, L. AU - Cao, B. AU - Liu, Y. AU - Zhao, L. AU - Lu, B. AU - Li, B. AU - Chen, J. AU - Wang, C. PY - 2020 DA - 2020// TI - Clinical outcomes of ceftazidime-avibactam in lung transplant recipients with infections caused by extensively drug-resistant gram-negative bacilli JO - Ann Transl Med VL - 8 UR - https://doi.org/10.21037/atm.2019.10.40 DO - 10.21037/atm.2019.10.40 ID - Chen2020 ER - TY - JOUR AU - Sternbach, N. AU - Leibovici Weissman, Y. AU - Avni, T. AU - Yahav, D. PY - 2018 DA - 2018// TI - Efficacy and safety of ceftazidime/avibactam: a systematic review and meta-analysis JO - J Antimicrob Chemother VL - 73 UR - https://doi.org/10.1093/jac/dky124 DO - 10.1093/jac/dky124 ID - Sternbach2018 ER - TY - STD TI - Shields RK, Clancy CJ, Pasculle AW, Press EG, Haidar G, Hao B, Chen L, Kreiswirth BN, Nguyen MH. Verification of ceftazidime-avibactam and ceftolozane-tazobactam susceptibility testing methods against carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol. 2018;56(2). ID - ref14 ER - TY - STD TI - Kresken M, Korber-Irrgang B. Performance of the Etest for susceptibility testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa toward ceftazidime-avibactam. J Clin Microbiol. 2018;56(9). ID - ref15 ER - TY - STD TI - Sader HS, Rhomberg PR, Chandrasekaran S, Trejo M, Fedler KA, Boyken LD, Diekema DJ. Correlation between broth microdilution and disk diffusion results when testing ceftazidime-avibactam against a challenge collection of Enterobacterales isolates: results from a multilaboratory study. J Clin Microbiol. 2020;58(4). ID - ref16 ER - TY - STD TI - Sader HS, Rhomberg PR, Huband MD, Critchley IA, Stone GG, Flamm RK, Jones RN. Assessment of 30/20-microgram disk content versus MIC results for ceftazidime-avibactam tested against Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol. 2018;56(6). ID - ref17 ER - TY - STD TI - CLSI. Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI supplement M100. Wayne: Clinical and Laboratory Standards Institute; 2020. ID - ref18 ER - TY - STD TI - CLSI. Performance standards for antimicrobial disk susceptibility tests. 12th ed. M02-A12. Wayne, PA: Clinical and Laboratory Standards Institute, 2015. ID - ref19 ER -